Início
Explorar
nav.journalClub
Tendências
Mais
synapse
⌘+K
Idioma
Português
Português
Malignancy, mortality, and morbidity: Autoimmune encephalitis in the ICU | Synapse
March 3, 2026
Malignancy, mortality, and morbidity: Autoimmune encephalitis in the ICU
KT
Kevin Soon Hwee Teo
CT
Christopher Thong
National University Hospital
YG
Yihui Goh
National University of Singapore
See all
Key Points
High mortality rates are associated with autoimmune encephalitis in ICU patients, indicating severe illness.
Survival analysis shows that malignancy significantly impacts patient outcomes, with poorer survival rates observed.
Assessment of clinical outcomes reveals substantial morbidity among those treated for autoimmune encephalitis in ICU settings.
The findings emphasize the need for early detection and treatment of autoimmune conditions to improve outcomes.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Teo et al. (Mon,) studied this question.
synapsesocial.com/papers/69a75f71c6e9836116a2ad19
https://doi.org/https://doi.org/10.1016/j.jns.2025.124567